Thursday, October 12, 2017 6:57:30 PM
From today's news release:
"On September 22, 2017, the Company received labeling comments from the FDA which the Company responded to on September 29, 2017."
My guess is that from this communication, suspicions began to rise at the company.
IF SO, it would seem that this insider trade was border line illegal.
I'm obviously disappointed because the trial results were excellent. They still have other drugs with PDUFAs coming up so I'm not selling. In fact, if it falls significantly tomorrow, I may pick up some more shares.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM